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The C-type lectin CD161 is expressed by a large
proportion of human T lymphocytes of all lineages,
including a population known as mucosal-associated
invariant T (MAIT) cells. To understand whether dif-
ferent T cell subsets expressing CD161 have similar
properties, we examined these populations in parallel
using mass cytometry and mRNA microarray appro-
aches. The analysis identified a conserved CD161++/
MAIT cell transcriptional signature enriched in
CD161+CD8+ T cells, which can be extended to
CD161+ CD4+ and CD161+TCRgd+ T cells. Further-
more, this led to the identification of a shared
innate-like, TCR-independent response to interleukin
(IL)-12 plus IL-18 by different CD161-expressing T cell
populations. This response was independent of regu-
lation by CD161, which acted as a costimulatory
molecule in the context of T cell receptor stimulation.
Expression of CD161 hence identifies a transcrip-
tional and functional phenotype, shared across hu-
man T lymphocytes and independent of both T cell
receptor (TCR) expression and cell lineage.
INTRODUCTION
T lymphocytes form a major arm of the adaptive response, with
somatic recombination of the T cell receptor (TCR) enabling
recognition of a wide variety of antigens, coupled with the ability
to form immunological memory. Although developing from a
common thymic precursor, T lymphocytes may develop to ex-Cell Rpress a TCR composed of either gd chains or, more convention-
ally in humans, of ab. TCRab+ T cells subsequently develop to be
either CD8+ or CD4+, displaying distinct functions and restricted
by major histocompatibility complex (MHC) class I or II mole-
cules, respectively. These subsets display further subdivisions,
with differentiation of CD4+ T cells into defined helper cell sub-
sets characterized by unique cytokine production, transcription
factor expression, and surface phenotype. For example, the
more recently defined Th17 subset is characterized by secretion
of interleukin (IL)-17, the master transcription factor RORgt (An-
nunziato et al., 2007), and expression of the C-type lectin CD161
(Cosmi et al., 2008).
Expression of CD161 is not restricted to CD4+ Th17 cells,
however. Originally a marker of natural killer (NK) cells (Lanier
et al., 1994; Yokoyama and Seaman, 1993), T cell expression
of CD161 was identified two decades ago on both CD4+ and
CD8+ (Lanier et al., 1994), and later on TCRgd+ (Battistini
et al., 1997), T cells. Indeed, a quarter of both TCRab+ T cells (La-
nier et al., 1994) and TCRgd+ T cells (Battistini et al., 1997) ex-
press this C-type lectin, and thus CD161 is expressed by a large
proportion of human T cells. Within CD8+ T cells, two popula-
tions are evident, expressing either intermediate or high levels
of CD161 (CD161+ or CD161++; Takahashi et al., 2006), with
the latter shown to consist mainly of mucosal-associated
invariant T (MAIT) cells (Martin et al., 2009; Ussher et al., 2014).
MAIT cells are a family of innate-like human T cells that display
a somatically recombined yet semi-invariant TCR, composed of
the TCR a chain Va7.2-Ja33/12/20 (Reantragoon et al., 2013;
Tilloy et al., 1999) pairedwith a biasedVb repertoire (Reantragoon
et al., 2013; Walker et al., 2012). Expression of this TCR restricts
MAIT cells to the MHC class Ib antigen-presenting molecule
MR1, which presents riboflavin precursors (Corbett et al., 2014;
Kjer-Nielsen et al., 2012) produced by a variety of bacteria toeports 9, 1075–1088, November 6, 2014 ª2014 The Authors 1075
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activate MAIT cells. Whereas originally identified within the dou-
ble-negative T cell fraction (Porcelli et al., 1993), approximately
90% of MAIT cells in humans are CD8+ (either CD8aa or ab;
Walker et al., 2012), although aminor fraction of CD4+MAIT cells
also exists (Reantragoon et al., 2013). Yet, independently of cor-
eceptor expression, all MAIT cells are identified by high expres-
sion of CD161 (Dusseaux et al., 2011; Martin et al., 2009).
CD161 isahomodimericC-type lectin,which represents thesin-
glehumanorthologof the familyofNKRP1genes in rodents (Lanier
et al., 1994), and thus studyofMAITandCD161-expressingT cells
is currently restricted to the human system.MurineNKRP1 recep-
tors recognize non-MHC ligands of the C-type lectin-related (Clr)
family, encoded by genes interspersed within the NKRP1 genes
themselves (Iizuka et al., 2003; Plougastel et al., 2001). Similarly,
CD161 binds the human ortholog of Clr-b, known as lectin-like
transcript 1 (LLT1) (Aldemir et al., 2005; Rosen et al., 2005).
Whereas the outcome of CD161 ligation on NK cells is generally
accepted to be inhibitory (Aldemir et al., 2005; Lanier et al.,
1994; Rosen et al., 2005), the effect on T cells is less clear, with re-
ports of both costimulatory (Aldemir et al., 2005; Exley et al., 1998)
and inhibitory (Le Bourhis et al., 2013; Rosen et al., 2008) effects.
Both CD161++ MAIT cells and CD161+CD4+ T cells display a
type 17 phenotype (Billerbeck et al., 2010; Cosmi et al., 2008;
Dusseaux et al., 2011). This phenotype appears preprog-
rammed, with precursors of both MAIT and Th17 cells identified
within umbilical cord blood by expression of CD161 (Cosmi et al.,
2008; Walker et al., 2012). Indeed, a highly significant correlation
in gene expression in CD161++CD8+ T cells between cord blood
and adults was demonstrated, despite only aminor proportion of
CD161++CD8+ T cells expressing the MAIT cell TCR at birth
(Walker et al., 2012). Furthermore, CD161 has previously been
shown to identify T cells with the potential to produce IL-17
(Maggi et al., 2010). Therefore, we asked whether expression
of CD161 marked cells with a shared phenotypic or transcrip-
tional profile, both within and across previously defined T cell
subsets, and further whether this corresponded to a specific
shared function between these otherwise disparate cell types.
RESULTS
CD161++ CD8+ T Cells, Including Both Va7.2+ MAIT and
Va7.2 Populations, Share a Common Phenotype
MAIT cells express an invariant TCR a chain (Va7.2) together with
high levels of CD161 (Dusseaux et al., 2011) and predominantlyFigure 1. Polyclonal Va7.2CD161++ CD8+ T Cells Are Not Activate
Stimulation by IL-12+IL-18
(A) Percentage Va7.2+ of CD161++CD8+ T cells (histogram) and percentage CD1
(n = 8). Representative flow cytometry plots shown above.
(B) Comparison of TCR Vb usage by Va7.2+ and Va7.2 CD161++ CD8+ T cells
(C) Proportional Va (38 sequences) and Vb (129 sequences) usage by Va7.2 C
(D) Percentage of IFNg expression by Va7.2+ or Va7.2CD161++ CD8+ T cell su
of anti-MR1 (10 mg/ml) or corresponding isotype control (n = 11). **p < 0.01; one-w
(E) Percentage of IFNg expression by sorted Va7.2+ or Va7.2CD161++CD8+ T c
by paired t test.
(F) Transcription factor expression as determined by flow cytometry. Graphs s
(CD3+CD8+ cells excluding CD161++) and Va7.2+ or Va7.2 CD161++ CD8+ T
comparison test. Representative histograms show isotype (gray), Va7.2+ (green
All data are represented as mean ± SEM. See also Figure S1.
Cell Rexpress the CD8 coreceptor (>90%; Walker et al., 2012).
Whereas Va7.2+ MAIT cells represent the vast majority of the
CD161++ CD8+ T cell population (<95%) in adult blood, a pop-
ulation of CD161++CD8+ T cells that are Va7.2 is also evident
(Figure 1A), comprising an average of 11.41% (±6.99%) of
CD161++CD8+ T cells in healthy adults. We first investigated
the identity of this additional CD161++CD8+ T cell population
in relation to MAIT cells. In cord blood, where CD161++CD8+
T cells are already preprogrammed to a MAIT-like, type-17
phenotype (Walker et al., 2012), this Va7.2 population
comprised the major proportion of CD161++CD8+ T cells
(84.69% ± 8.44%). After birth, Va7.2+MAIT cell expansion drives
the MAIT cell domination of the CD161++ population (Gold et al.,
2013; Leeansyah et al., 2014), and a corresponding reduction in
the proportion of Va7.2 cells was seen. This was evident as
early as 24 months, where the MAIT cell population represented
nearly 75% of the CD161++CD8+ T cell population (Figure 1A).
In addition to invariant expression of Va7.2, MAIT cells display
semi-invariant TCR b usage (Figure 1B) with predominant use of
Vb2 and Vb13.2, as previously described (Reantragoon et al.,
2013;Walker et al., 2012). In contrast, a panel of Vb antibodies re-
vealed nondiscriminate Vb usage by Va7.2 CD161++CD8+
T cells. We further investigated the TCR repertoire of this popula-
tion by TCR sequencing, performed on single cells, as described
(Wang et al., 2012). This confirmed Vb usage by Va7.2
CD161++CD8+ T cells to be polyclonal. Furthermore, polyclonal-
ity within a chain usagewas also evident, with expression of a va-
riety of a chains both within and between donors (Figure 1C).
The semi-invariant MAIT cell TCR recognizes bacterially
derived riboflavin precursors presented by the antigen-present-
ing molecule MR1 (Corbett et al., 2014; Kjer-Nielsen et al., 2012).
MHC-tetramer-positive populations against various viral epi-
topes are rarely CD161++ (J.R.F., unpublished data). Therefore,
to establish the MR1 reactivity of Va7.2CD161++CD8+ T cells,
we used a 5 hr coculture assay in which we have previously
described MAIT cells to be activated via the TCR to produce
interferon g (IFNg) (Ussher et al., 2014). Here, THP1s were incu-
bated with fixed Escherichia coli (E. coli) overnight and then
cultured with sort-purified Va7.2+ or Va7.2 CD161++CD8+
T cells. As expected, CD161++Va7.2+ MAIT cells produced
IFNg in response to THP1s + E. coli, and these responses
were blocked by addition of anti-MR1 (Figure 1D). Whereas in
two donors, a limited MR1-mediated response by Va7.2
CD161++CD8+ T cells to E.coli was apparent, the majority ofd in an MR1-Dependent Manner but, like MAIT Cells, Respond to
61++ of CD8+ T cells (red point) in cord (n = 3), 24 month (n = 8), and adult blood
using a TCR Vb antibody panel.
D161++CD8+ T cells as determined by single-cell TCR sequencing (n = 3).
bsets cocultured with THP1 cells exposed to E. coli in the presence or absence
ay ANOVAwith Dunnett’s multiple comparisons test compared to E. coli alone.
ells incubated overnight with IL-12 + IL-18 at 50 ng/ml (n = 9). ns, not significant
how GeoMFI of RORgt (left) and PLZF (right) by conventional CD8+ T cells
cells (n = 5). ****p < 0.0001; **p < 0.01; one-way ANOVA with Tukey’s multiple
line), and Va7.2 (red) for each transcription factor.
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donors did not respond to bacteria. No response was observed
in sorted conventional (MHC-restricted) CD161+CD8+ T cells
(data not shown). This was reflected in 24-month-old donors
where no response was observed from Va7.2 CD161++CD8+
T cells when peripheral blood mononuclear cells (PBMCs)
were incubated for 5 hr with E. coli-loaded THP1s (Figure S1).
In addition to MR1-mediated stimulation through the TCR,
MAIT cells are also activated by a combination of IL-12+IL-18
in a TCR-independent, innate manner, a characteristic that
was shared by other CD161++CD8+ T cells (Ussher et al.,
2014). Gating of both CD161++CD8+ T cell populations in adult,
24-month-old, and cord blood donors again showed that both
Va7.2+ and Va7.2 portions were capable of IFNg production
(Figure S1). We confirmed this in sorted adult populations, where
both Va7.2+ and Va7.2 CD161++CD8+ T cells produced IFNg
in response to cytokine stimulation (Figure 1E), indicating this as
a feature of CD161++CD8+ T cells as a whole.
We next asked whether Va7.2 CD161++CD8+ T cells shared
the characteristic transcription factor expression of MAIT cells,
namely expression of RORgt, associated with the type-17 profile
of MAIT cells (Billerbeck et al., 2010; Dusseaux et al., 2011) and
promyelocytic leukemia zinc finger (PLZF), related to the innate-
like effector differentiation of MAIT and NK T (NKT) cells (Savage
et al., 2008). Expression of these transcription factors by Va7.2
CD161++CD8+ was significantly (p < 0.01) higher than in con-
ventional CD8+ T cells but expressed on average at slightly lower
levels than MAIT cells (Figure 1F). Va7.2 CD161++CD8+ T cells
also principally displayed an effector memory (CD62L
CD45RA) phenotype, as seen in Va7.2+ MAIT cells (Figure S1).
Together, these results illustrate that, despite different TCR
expression and restriction, both Va7.2+ MAIT and Va7.2
CD161++CD8+ T cells share a preprogrammed phenotype and
an innate ability to respond to cytokine stimulation and can
therefore be viewed as a common population related through
high expression of CD161.
Analysis of CD161-Expressing CD8+ T Cells by CyTOF
Next, we wanted to investigate whether expression of CD161,
and specifically different levels of expression, defined distinct
CD8+ T cell phenotypes (Figure 2A). To do this, we assayed
expression of 23 markers (see the Supplemental Experimental
Procedures) simultaneously across phorbol 12-myristate 13-ac-
etate (PMA) + ionomycin-stimulated CD8+ T cells by mass cy-
tometry (CyTOF), using principal-component analysis (PCA) to
integrate the patterns of expression into a smaller number of
summary values (Newell et al., 2012). PCA looks for directions,
or components, that cumulatively account for the variation con-
tained within the data set, with the first four components here ac-
counting for >60% of the total variation (Figure 2B). This analysis
allowed the patterns of expression of all 23 markers to be sum-
marized for each cell, which can then be viewed on a 2D or 3D
plot, thereby allowing the different CD8+ T cell populations to
be viewed in relation to one another.
When stimulated CD8+ T cells were plotted upon the first three
components, CD161++ cells occupied a distinct niche com-
pared to the other CD8+ T cell subsets (Figure 2C; Movie S1).
Similarly, when plotted in 2D on component 1, which accounts
for the most variation, and component 4, to which CD1611078 Cell Reports 9, 1075–1088, November 6, 2014 ª2014 The Authcontributed the most to the variation described (component
loading; Figure 2B), CD161++ cells again occupied a distinct
niche among the spectrum of CD8+ T cell phenotypes
(Figure 2D).
The progression in phenotypes of CD8+ T cells that expressed
differing levels in CD161, and the niches they occupied, could be
most clearly seen when components 1,2, and 4 were viewed
together (Movie S2). In addition to CD8+ T cells that express
high levels of CD161, a population of CD8+ T cells that express
low, or intermediate, levels of CD161 is also apparent in the cir-
culation (CD161+; Figure 2A). These cells displayed an overlap
with the phenotypic niche of CD161++ cells (Movie S1;
Figure 2D).
The Phenotypic and Transcriptional Profile
of CD161+CD8+ T Cells Overlaps with CD161++CD8+
T Cells
To explore in more depth the phenotypic overlap of CD161+ and
CD161++/MAIT CD8+ T cells, we probed genome-wide RNA
expression of these CD8+ T cell populations by microarray. Pre-
viously, we identified a set of genes differentially expressed by
CD161++CD8+ T cells compared to CD161 CD8+ T cells (Fig-
ure 3A; Billerbeck et al., 2010). This included the upregulated
expression of RORgt, CXCR6, and IL18 receptor (IL18R). Given
the dominance of MAIT cells within the CD161++CD8+ T cell
population, these markers are consequently thought to be
descriptive of the MAIT cell subset as well. Similarly, we per-
formed microarray analysis on CD161+CD8+ T cells in compar-
ison to CD161CD8+ T cells in the same donors (Figure 3B) and
identified 544 differentially expressed genes. When compared
with the CD161++/MAIT cell transcriptional signature, 79% of
those genes significantly differentially expressed by CD161+
CD8+ T cells were shared by CD161++CD8+ T cells (Figure 3C;
Tables S1 and S2). Although the majority of shared genes were
downregulated, among the 107 shared upregulated genes
were those characteristic of MAIT cells, including CCR6,
CXCR6, ABCB1 (encoding MDR1), and IL18R (Billerbeck et al.,
2010; Dusseaux et al., 2011).
Next, we analyzed the gene expression data as a whole using
gene set enrichment analysis (GSEA) (Subramanian et al., 2005),
rather than limiting analysis to significant genes, which may miss
relevant biological differences or pathway effects. GSEA orders
the genes into a ranked list according to their differential expres-
sion between CD161+ and CD161 CD8+ T cells. The locations
of the CD161++CD8+ T-cell-associated genes, divided into up-
regulated (those upregulated within CD161++CD8+ T cells) or
downregulated (upregulated within CD161CD8+ T cells; Fig-
ure 3A) genes, within this ranked list were then identified. We
found significant enrichment of genes upregulated in CD161++
CD8+ T cells in CD161+CD8+ T cells (normalized enrichment
score [NES] = 3.79; p < 0.001) and corresponding enrichment
of downregulated genes with those genes more associated
with a CD161 phenotype (NES = 3.12; p < 0.001; Figure 3D).
The correlation of CD161 expression with a number of
‘‘MAIT cell markers’’ identified among these shared upregulated
genes was then investigated at the protein level using flow
cytometric analysis. To prevent skewing by the differing propor-
tions of each subset, defined as CD161++, CD161+, andors
Figure 2. CyTOF and Principal-Component Analysis Reveals CD161++ Cells to Be Unique among CD8+ T Cells
(A) Representative flow cytometry plot of the division of CD8+ T cells into three subsets based upon expression of CD161.
(B) Data generated for PMA + ionomycin-stimulated CD8+ T cells were analyzed by principal-component analysis (PCA). The percent variation explained is
plotted for each component (bars) and cumulatively (line), and the PCA parameter loadings (weighting coefficients) for the first four components are shown.
(C) Stimulated CD8+ T cells from one representative donor are plotted on the first three components as a bulk population (black) and for the three subsets:
CD161++ (green); CD161+ (blue); and CD161 (red).
(D) Density plots of bulk-stimulated CD8+ T cells are plotted on component 1 and component 4 and are overlaid with contour density of plots of CD161++ (green),
CD161+ (blue), and CD161 (red) cells.CD161 (Figure 2A), we gated on each individual subset and
plotted the expression levels of eachmarker, taken as geometric
meanfluorescence intensity (GeoMFI), in relation to that ofCD161
expression (Figure 3E). This revealed a highly significant correla-
tion (p < 0.0001) between the levels of CD161 expressed and the
expression of theCCR6 (r2 = 0.9143), CXCR6 (r2 = 0.9258),MDR1
(r2 = 0.9322), and IL18Ra (r2 = 0.9554). Therefore, expression ofCell RCD161 by CD8+ T cells correlates with a phenotypic signature
that includes a distinct set of chemokine and cytokine receptors.
Conserved Transcriptional Changes in CD161-
Expressing CD4+ and TCRgd+ T Cells
A population of CD4+ T cells expressing CD161 is also apparent
in the adult circulation and cord blood (Figure 4A). Botheports 9, 1075–1088, November 6, 2014 ª2014 The Authors 1079
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CD161+CD4+ T cells (Cosmi et al., 2008; Maggi et al., 2010) and
CD161++ CD8+/MAIT cells (Billerbeck et al., 2010; Dusseaux
et al., 2011) have been associated with a type-17 phenotype.
Therefore, we investigated phenotypic overlap on a global scale
by performing gene-expression profiling of CD161+CD4+ T cells
by microarray. Genes significantly differentially expressed
compared to CD161CD4+ T cells were identified and compared
to the CD161++CD8+ gene data set. CD161+CD4+ T cells shared
a third of distinguishing genes with CD161++CD8+ T cells,
including IL18RAP (Figure 4B; Tables S3 and S4). Again, GSEA
demonstrated significant enrichment (p < 0.001) of those genes
upregulated in CD161++CD8+ T cells in the CD161+CD4+ tran-
scriptional profile (NES = 2.45) and downregulated genes with
the CD161CD4+ phenotype (NES = 3.04; Figure 4C), demon-
strating concordance of transcriptional profiles, independently of
coreceptor expression among TCRab+ T cells expressingCD161.
To investigate whether the CD161++/MAIT phenotype was also
enriched in T cells expressing a different TCR, we extended our
analysis to TCRgd+ T cells. Again, both CD161+ and CD161
TCRgd+ T cells are evident within the adult circulation and cord
blood (Figure 4D). Gene-expression analysis was performed on
sortedCD161+ andCD161 TCRgd+ T cells and those genes sig-
nificantly differentially expressed identified (Figure 4E). Approxi-
mately a fifth of these were again shared with the CD161++
CD8+genedata set, including IL18R1andABCB1,whichencodes
MDR1 (Tables S5 and S6). As seen for CD8+ and CD4+ T cells,
GSEA revealed theCD161++CD8+ gene set to be significantly en-
riched (p<0.001) inCD161+TCRgd+Tcells, corresponding toboth
upregulated (NES=2.78) anddownregulated (NES=2.62) genes
(Figure 4F), despite a reduced number of genes being shared.
Overall, CD161 expression can distinguish distinct popula-
tions of T cells within each T cell lineage, whether CD8+,
CD4+, or TCRgd+, with a defined CD161++/MAIT-cell-associ-
ated transcriptional signature enriched within this CD161-posi-
tive subset. Moreover, comparison of the leading edge gene
set (the core set of genes that account for this enrichment)
from each T cell population distinguished a core of 124 upregu-
lated (Table 1) and 199 downregulated (Table S7) genes
commonly enriched in all CD161-expressing T cells and which
therefore defines the CD161-associated transcriptional signa-
ture. This included upregulated expression of ABCB1 (MDR1),
RORC (RORg), ZBTB16 (PLZF), IL12RB2, and IL18R1.
ACommon Functional Correlate of CD161 Expression in
All T Cell Subsets
IL18R was one of the defining components of the leading edge
gene set associated with CD161 expression. The receptor isFigure 3. CD161+CD8+ T Cells Share a CD161++ Transcriptional Signa
(A) Heatmap showing 3,025 significantly (p < 0.05) differentially expressed trans
clustered by one minus Pearson correlation.
(B) Heatmap showing 544 significantly differentially expressed genes between CD
one minus Pearson correlation.
(C) Pie chart shows proportion of genes differentially expressed by CD161+ that a
diagram shows breakdown of upregulated and downregulated genes unique to
(D) Gene set enrichment summary plots for vsn-normalized CD161+ versus CD
regulated (bottom) gene sets. Normalized enrichment score (NES) = 3.79, p < 0.
(E) GeoMFI of CD161 for CD161++ (green), CD161+ (blue), and CD161 (red) C
CXCR6 (r2 = 0.9258; p < 0.0001), MDR1 (r2 = 0.9322; p < 0.0001), and IL18Ra (r2 =
Cell Rcomposed of two subunits: IL18Ra and IL18RAP. IL18R1
(IL18Ra) was significantly upregulated in CD161+TCRgd+ (p <
0.01) and both CD161-positive populations of CD8+ (p <
0.0001) T cells and IL18RAP significantly upregulated in all
CD161-expressing T cell subsets (p < 0.0001; Figure 5A).
Expression was confirmed at the protein level by flow cytometry,
which also revealed a previously unappreciated CD161++
IL18Ra++ subset among CD4+ and TCRgd+ T cells (Figure 5B).
Gating of these three subsets (CD161++, CD161+, and CD161)
revealed a significant correlation between CD161 expression
and IL18Ra expression (Figure 5C) among CD4+ (p < 0.0001)
and TCRgd+ (p = 0.0001) T cells, as for CD8+ T cells (Figure 3E).
We recently described that elevated expression of IL18R en-
ables CD161++CD8+/MAIT cells to be activated by IL-12+IL-18
in a TCR-independentmanner (Ussher et al., 2014). As genes en-
coding both subunits of the IL-18R and IL12RB2were contained
within the core leading edge set of CD161-associated upregu-
lated genes (Table 1), we assayed IFNg production in response
to overnight stimulation with IL-12+IL-18 in CD8+, CD4+, and
TCRgd+ T cells. IFNg production was apparent by intracellular
cytokine staining in all three T cell lineages and particularly
apparent within the CD161++ population of each (Figure 5D).
Although CD4+ MAIT cells do exist (Reantragoon et al., 2013),
IFNg responses were not restricted to Va7.2+CD4+ T cells (Fig-
ure S2). We correlated this response to IL12+IL18 with the levels
of CD161 expressed by gating on the three CD161 populations
(CD161++, CD161+, and CD161) within each T cell lineage,
as previously (Figure 5B). As expected, there was a significant
correlation between levels of CD161 expressed by each popula-
tion and the percentage of that population expressing IFNg in
response to IL-12+IL-18 (Figure 5E), with the greatest responses
seen by the CD161++ population in each.
Together, these results demonstrate CD161-positive T lym-
phocytes to be related both in terms of gene expression and
function, including elevated expression of IL18R in the resting
state. This is linked to their shared ability to make an innate
response to cytokine stimulation by IL-12+IL-18, which is inde-
pendent of the TCR yet correlated to expression of CD161.
Regulation by CD161
Expression of CD161 by NK cells is generally accepted to nega-
tively regulate NK cell functions (Aldemir et al., 2005; Lanier et al.,
1994; Rosen et al., 2005), whereas the effect of CD161 ligation on
T cell function is less clear (Aldemir et al., 2005; Exley et al., 1998;
Le Bourhis et al., 2013; Rosen et al., 2008). To investigate the role
of CD161 in the response to IL12+IL18, we ligated CD161 by
adding biotin beads coated with anti-CD161 into the culture.ture and Phenotypic Profile
cripts between CD161++ and CD161 CD8+ T cells in four donors. Subsets
161+ and CD161CD8+ T cells in the same four donors. Subsets clustered by
re shared with CD161++ (79%) when compared to CD161CD8+ T cells. Venn
or shared by each subset.
161 CD8+ T cell ranked genes and CD161++ upregulated (top) and down-
001 upregulated genes; NES = 3.12, p < 0.001 downregulated genes.
D8+ T cell subsets correlated with GeoMFI of CCR6 (r2 = 0.9143; p < 0.0001),
0.9554; p < 0.0001); n = 5. Representative flow cytometry plots shown for each.
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Figure 4. CD161+CD4+ and CD161+TCRgd+ T Cells Are Enriched for the CD161++CD8+/MAIT Transcriptional Signature
(A) Representative flow cytometry plot showing CD161+CD4+ T cells within adult and cord blood.
(B) Heatmap showing 169 significantly differentially expressed genes between CD161+ and CD161 CD4+ T cells in three donors. Subsets clustered by one
minus Pearson correlation. Pie chart shows proportion of genes differentially expressed by CD161+CD4+ that are shared with CD161++CD8+ (33%), when
compared to their CD161 counterparts. Venn diagram shows breakdown of upregulated and downregulated genes unique to or shared by each subset.
(legend continued on next page)
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Table 1. Core Transcriptional Signature of CD161-Associated
Upregulated Genes
ABCA2 CTNNA1 IGFBP4 MYO1F SESN1
ABCB1 CTSH IL12RB2 NADK SIPA1L2
ACTN4 CXCR6 IL15 NBEAL2 SLAMF1
ADCY9 CXXC5 IL18R1 NETO2 SLC1A5
ADRB2 CYB561 IL18RAP NPC1 SLC2A8
AGPAT4 CYFIP1 IL23R PBX4 SLC7A5
ALCAM DENND3 IRAK2 PERP SLCO3A1
ARNTL DUSP5 JSRP1 PHACTR2 SMAD3
AUTS2 EIF2C4 KIAA1539 PHLDA1 SMAD7
B4GALT1 ELOVL4 KIF5C PIK3AP1 SNAI3
CACNA2D2 ELOVL6 KLRB1 PLCB1 SYNE2
CACNA2D4 ERN1 KLRG1 PLEKHG3 SYTL2
CAMTA1 FAM43A LAG3 PLXNC1 THBS1
CAPN12 FAS LATS2 PODXL TLE1
CCR2 FOSL2 LONRF3 PRDM1 TNF
CD58 GALM LTB4R PRDM8 TNFRSF18
CD72 GBP5 LTK PRF1 TNFSF14
CERK GFPT2 MAFF PTGDS TPM2
CFH GPR65 MAP3K5 PTPRM VCL
CLCF1 GPR68 MAP3K8 RAB11FIP1 VLDLR
CLIC5 GTF3C1 MATK RASD1 WNT1
COL5A1 GZMA ME1 RHBDF2 YPEL1
COL5A3 GZMK METRNL RORA ZBTB16
COLQ IFI44 MICALCL RORC ZDHHC14
CREB3L2 IFNGR1 MYO1D RPPH1
Leading-edge analysis was performed on the enriched CD161++CD8+
T cell upregulated gene set in all T cell subsets. The leading-edge gene
set was compared from each T cell population and a core set of 124
genes identified and listed in alphabetical order. Those referred to in
the text are underlined.Ligation of CD161, either by its ligand LLT1 or anti-CD161, in-
duces transient downregulation inCD161 expression (Figure S3).
Therefore, this analysis could only be reliably performed onMAIT
cells, which can be tracked independently through expression of
Va7.2. Ligation of CD161 had no effect on MAIT cell expression
of IL18R (Figure 6A) or IFNg production in response to IL-12+IL-
18 (Figure 6B). Previously, CD161 has been shown to regulate re-
sponses only in the context of TCR stimulation (Aldemir et al.,
2005; Exley et al., 1998); therefore, we examined the effect of
CD161 ligation in addition to stimulation through the TCR. Liga-
tion of CD161 induced a significant increase in IFNg (p < 0.01)
and tumor necrosis factor alpha (TNF-a) (p < 0.05) production(C) Gene set enrichment summary plots for vsn-normalized CD161+ versus CD
downregulated (right) genes. NES = 2.45, p < 0.001 upregulated genes; NES = 
(D) Representative flow cytometry plot showing CD161+TCRgd+ T cells within a
(E) Heatmap showing 828 significantly differentially expressed genes between C
minus Pearson correlation. Pie chart shows proportion of genes differentially exp
compared to their CD161 counterparts. Venn diagram shows breakdown of up
(F) Gene set enrichment summary plots for vsn-normalized CD161+ versus CD1
downregulated (right) genes. NES = 2.78, p < 0.001 upregulated genes; NES = 
Cell Rwhen MAIT cells were stimulated with anti-CD3 and anti-CD28
compared to cells stimulated with anti-CD3 and anti-CD28 alone
(Figures 6C and 6D). This suggests, along with published data
(Aldemir et al., 2005; Exley et al., 1998) and other data using sol-
uble anti-CD161 (data not shown), that CD161 can act as a cos-
timulatory receptor to increase the response to TCR stimulation.
DISCUSSION
Conventionally, T lymphocyte subsets have been identified and
divided based upon the expression of sets of proteins, including
cell surface markers, cytokines, and nuclear transcription fac-
tors. The C-type lectin CD161 is expressed by a large proportion
of cells within each of these previously defined subsets, in-
cluding MAIT, CD4+ and CD8+, and both TCRab+ and TCRgd+
T cells. Despite the diverse phenotypes and functions of these
individual T cell subsets, associated with their recognition of
distinct antigens on specific antigen-presenting molecules, we
have demonstrated these cell lineages to be related by a shared
transcriptional signature and innate-like function and marked by
expression of CD161.
Among those T cells expressing the highest levels of CD161 is
the population of innate-like, unconventional T cells known as
MAIT cells. This population is distinct in terms of TCR expression
(Tilloy et al., 1999), antibacterial function (Le Bourhis et al., 2010),
and type-17-related transcriptional andphenotypic profile (Biller-
beck et al., 2010). This study represents a phenotypic description
of CD161++CD8+MAIT cells bymultiparametricmass cytometry
(CyTOF). Despite inclusion of only ‘‘conventional’’ T cell markers
within the 23-parameter panel, rather than the unique markers
characteristic ofMAIT cells, PCA emphasized the distinctiveness
of this population, which segregates within a discrete niche in
the spectrum of CD8+ T cell phenotypes. It would be of interest
to identify the location of the Va7.2 CD161++CD8+ T cell pop-
ulation in relation to Va7.2+ MAIT cells within the spectrum of
CD8+ T cell phenotypes, which was precluded here by the
absence of an isotope-tagged Va7.2 antibody.
Although the Va7.2CD161++CD8+ T cell population is highly
heterogeneous in terms of both TCR a and b chain expression,
both Va7.2+ and Va7.2 CD161++ subsets expressed a mem-
ory phenotype and elevated levels of the polarizing transcription
factors RORgt and PLZF. The central role of PLZF in directing the
innate-like functions of NKT and MAIT cells (Savage et al., 2008)
and other innate lymphocytes (Constantinides et al., 2014)
has recently been revealed. The shared expression by Va7.2
CD161++CD8+ T cells, early in development (Walker et al.,
2012), suggests that these cells may also display innate charac-
teristics. We investigated whether diverse Va7.2 cells repre-
sented a population analogous to type II NKT cells (Godfrey161 CD4+-T-cell-ranked genes and CD161++CD8+ upregulated (left) and
3.04, p < 0.001 downregulated genes.
dult and cord blood.
D161+ and CD161 TCRgd+ T cells in four donors. Subsets clustered by one
ressed by CD161+TCRgd+ that are shared with CD161++CD8+ (21%), when
regulated and downregulated genes unique to or shared by each subset.
61 TCRgd+-T-cell-ranked genes and CD161++CD8+ upregulated (left) and
2.62, p < 0.001 downregulated genes.
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Figure 5. CD161-Positive T Cell Subsets Express Elevated Levels of IL18Ra and Respond to Stimulation by IL-12+IL-18
(A) Relative expression levels of IL18R subunits by CD161-positive and CD161-negative sorted T cells and statistical significance from mRNA expression an-
alyses after normalization and correction formultiple testing. **p < 0.01; ****p < 0.0001. Floating bars showminimum andmaximum values, with a line at themean.
(B) Representative flow cytometry plots for IL18Ra expression in each T cell lineage, revealing CD161++, CD161+, and CD161 subsets in each (gated).
(C) GeoMFI of CD161 for CD161++ (green), CD161+ (blue), and CD161 (red) subsets in CD4+ and TCRgd+ T cells correlated with GeoMFI of IL18Ra. CD4 r2 =
0.8463, p < 0.0001; TCRgd r2 = 0.6890, p < 0.0001 (n = 5).
(D) PBMCs were stimulated overnight with 50 ng/ml IL-12+IL-18. Representative flow cytometry plots for IFNg expression by gated CD8+, CD4+, and TCRgd+
CD3+ live lymphocytes.
(E) GeoMFI of CD161 for CD161++ (green), CD161+ (blue), and CD161 (red) subsets in CD8+, CD4+, and TCRgd+ T cells correlated with percentage of each
subset expressing IFNg in response to overnight stimulation with IL-12+IL-18. CD8 r2 = 0.8853, p < 0.0001; CD4 r2 = 0.9378, p < 0.0001; TCRgd r2 = 0.8494, p <
0.0001 (n = 5).
See also Figure S2.
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Figure 6. CD161 Regulates TCR-Depen-
dent, but Not TCR-Independent, Responses
(A) GeoMFI of IL18Ra on Va7.2+CD8+CD3+ cells
incubated for 18 hr with biotin beads coated with
either IgG2a isotype or anti-CD161. ns, not sig-
nificant by paired t test (n = 9).
(B) Percentage of Va7.2+CD8+CD3+ cells ex-
pressing IFNg when cultured with 50 ng/ml IL-
12+IL-18 for 18 hr in the presence of biotin beads
coated with either IgG2a isotype or anti-CD161.
ns, not significant by paired t test (n = 9).
(C and D) Percentage of Va7.2+CD8+CD3+ cells
expressing IFNg (C) or TNF-a (D) when cultured
overnight with TCR-stimulating biotin beads,
coated either with anti-CD3 or anti-CD3 + anti-
CD28, in combination with IgG2a isotype (open
circles) or anti-CD161 (filled circles). *p < 0.05 and
**p < 0.01 by repeated-measures one-way ANOVA
(n = 8).
Data are represented as mean ± SEM. See also
Figure S3.et al., 2004), which recognize identical ligands to invariant NKT
cells, an additional innate-like lymphocyte subset, despite
diverse TCR expression (Gadola et al., 2002). It appears that
Va7.2 CD161++CD8+ T cells are not MR1 responsive in the
majority of donors; however, this does not rule out the possibility
that this populationmay be reactive to other nonclassical ligands
and warrants further investigation. Nonetheless, like Va7.2+
MAIT cells, Va7.2 CD161++CD8+ T cells are specifically acti-
vated by stimulation by IL-12+IL18, as shown here and else-
where (Ussher et al., 2014), representing a shared innate-like
feature of both populations of CD161++CD8+ T cells.
As MAIT cells displayed a phenotypic and functional relation-
ship to Va7.2 CD161++CD8+ T cells, we utilized mRNA micro-
array analysis to examine the relationship of MAIT cells to other
CD161-expressing T cell subsets. Previously, whole transcrip-
tome analysis by microarray has revealed that memory T and
B cells display a transcriptional signature that is shared with he-
matopoietic stem cells (Luckey et al., 2006), and transcripts that
distinguish T and B cells are also expressed among other
lymphocyte cell types (Painter et al., 2011). This indicates that
expression patterns and their consequent phenotypes may be
shared across previously defined divisions and may further be
suggestive of shared functional characteristics. In a similar
way, analysis of mRNA microarray data for CD161-positive
T cells, including TCRgd+, CD4+, and both populations of
CD8+ T cells, revealed a CD161-associated transcriptional
signature enriched in all T lymphocytes expressing CD161 and
led to the identification of a shared functional attribute.
The core transcriptional profile of CD161-expressing T cells
included genes for subunits of both the IL-12 and IL-18 recep-
tors, with high IL18Ra expression conserved across CD161-
positive T cells of all lineages. Expression of this receptor was
related to the ability of these cells to respond to IL-18 in combi-
nation with IL-12, inducing the innate TCR-independent produc-
tion of IFNg. Although this has previously been described for
CD161++ CD8+ T cells, including MAIT cells (Ussher et al.,
2014) and confirmed here for Va7.2CD161++, this has not
been described for other T cell subsets, with CD161++ subsetsCell Rin all lineages, identified among CD4+ and TCRgd+ T cells, dis-
playing the highest response levels. This establishes CD161 as
a marker of cells with an enhanced ‘‘innate’’ ability to respond
to this stimulus. Furthermore, this TCR-independent pathway
suggests a means by which these populations may be activated
in the inflammatory conditions in which they have been impli-
cated (Annibali et al., 2011; Billerbeck et al., 2010; Kang et al.,
2012; Kleinschek et al., 2009; Poggi et al., 1999).
The significance of CD161 expression by T cells has not yet
been fully determined. However, CD161 has previously been
applied as a marker of IL-17-expressing T cells (Maggi et al.,
2010), particularly Th17 cells (Cosmi et al., 2008), and may be
involved in the induction of this phenotype (Bai et al., 2014).
Whereas CD161 was shown here to mark cells with an innate-
like ability to respond to cytokine stimulation, ligation of CD161
had no effect on this response. Instead, CD161 was demon-
strated to function as a costimulatory receptor in the context of
TCR stimulation. This effect may differ from those shown by
others (Le Bourhis et al., 2013; Rosen et al., 2008) due to differ-
ences in the presentation of anti-CD161 or in the clones used
(see Figure S3D).
MAIT cells have previously been described to be hyporespon-
sive to stimulation through the TCR (Turtle et al., 2011), a feature
recently suggested to characterize all innate-like lymphocytes
(Wencker et al., 2014). This was related to low expression levels
of genes for multiple proteins that positively regulate TCR
signaling, including the genes ITK and MAL (Turtle et al., 2011).
Interestingly, these genes were also contained within the set of
core downregulated genes we identified here, being shared be-
tween all CD161-expressing T cells (Table S7). If similarly TCR
hyporesponsive, then by acting as a costimulatory receptor,
CD161 may help to overcome the reduced reactivity of the
TCR in these innate-like T cells (Wencker et al., 2014). Induction
of TCR hyporesponsiveness during development of innate-like
T cells has also been associated with the ability to respond to
cytokine stimulation and interestingly enabled identification by
Wencker et al. (2014) of an innate-like murine TCRgd+ T cell sub-
set that also responded selectively to IL-12 and IL-18.eports 9, 1075–1088, November 6, 2014 ª2014 The Authors 1085
In contrast to the current paradigms of T cell subdivision, this
study identifies a phenotype and function that is shared across
T cell lineages and marked by expression of CD161. Here, we
describe CD161 to identify cells with a shared transcriptional
profile, including high expression of IL18R, and capable of mak-
ing innate-type responses to cytokine stimulation. Therefore,
expression of CD161 marks human T cells with a distinct pheno-
type that is independent of lineage and identifies a family of
related lymphocytes with innate characteristics that includes
MAIT cells.
EXPERIMENTAL PROCEDURES
Cells
PBMCs were obtained from adults (whole blood leukocyte cones; NHS Blood
and Transplant), 24 month olds (prospective birth cohort; Saghafian-Hedeng-
ren et al., 2010), and umbilical cord blood samples (Stem Cell Services, NHS
Blood and Transplant) after appropriate ethical review. These were rested
overnight or stored in liquid nitrogen until required.
THP-1 cells (ECACC) were incubated with paraformaldehyde-fixed E. coli
(DH5a; Invitrogen) at 25 bacteria per cell overnight. PMBCs (24-month donors)
or sort-purified CD8+ T cells (adults; sorted on a MoFlo; Beckman Coulter
Genomics) were then added for a 5 hr coculture. Anti-MR1 (clone 26.5, kindly
provided by T.H. Hansen) or IgG2a isotype control (BD Biosciences) was
added at 10 mg/ml. For IL-12 + IL-18 stimulations, IL-12 (Miltenyi Biotec) and
IL-18 (R&D Systems) were added at 50 ng/ml overnight. In all cases, brefeldin
A (eBioscience) was added for the final 4 hr of incubation.
TCR Sequencing
T cell receptor sequencing of single cells was performed aspreviously described
(Wang et al., 2012). In brief, Va7.2+ and Va7.2 CD161++CD8+ T cells were
sorted (MoFlo; BeckmanCoulter) as single cells intowells of a 96-well plate con-
taining 2.5 ml of iScript cDNA Synthesis reaction mixture (Bio-Rad) with 0.1%
Triton X-100. TCR transcripts for each cell were amplified by multiplex nested
PCR using one unit of Platinum Taq DNA polymerase High Fidelity, 103 PCR
buffer, 2 mMmagnesium sulfate and 0.2 mM deoxynucleotide triphosphate (In-
vitrogen), 2.5 pmol of each external TRAV and TRBV primer and 10 pmol of each
external TRAC and TRBC in the first round, or the same concentration of either
internal TRAV and TRAC or internal TRBV and TRBC primers in the second
round (primers as detailed in Wang et al., 2012). The PCR conditions were
95C for 2 min, followed by 35 cycles of 95C for 20 s, 52C for 20 s, 72C for
45 s, followed by one cycle of 72C for 7 min. PCR products were purified
and sequenced with the corresponding TRAC or TRBC primer.
Microarrays
Cell sorting, RNA extraction, and microarray analysis of CD161 subsets within
CD8+ T cells was performed as previously described (Billerbeck et al., 2010).
CD4+ T cells were isolated from three donors by magnetic bead enrichment
(EasySep; STEMCELL Technologies) and CD161 subsets selected by staining
anti-CD161-phycoerythrin (PE); Beckman Coulter) followed by purification
with anti-PE MicroBeads (Miltenyi Biotec). Purity, as determined by flow
cytometry, was >95% for all samples. Total RNA was extracted using an
RNeasy Mini Kit (QIAGEN) and quality measured using the ND 1000 Spectro-
photometer (Saveen Werner). cRNA was amplified and purified using Illumina
TotalPrep RNA amplification kit (Ambion) and hybridized to the Illumina Hu-
manWG-6 v3.0 Expression BeadChip (Illumina).
For gene-expression profiling of TCRgd+ T cell subsets, T cells were en-
riched from PBMCs from four donors as per the manufacturer’s instructions
(EasySep T cell enrichment kit; STEMCELL Technologies). CD3+TCRgd+
CD161+ or CD161were sorted using a FACSAria (BD Biosciences). Cell pel-
lets were snap frozen and sent to Miltenyi Biotec Genomic Services (Bergisch
Gladbach) for RNA extraction and hybridization to Agilent Whole Human
Genome Oligo Microarray.
Microarray features were normalized using variance-stabilizing normaliza-
tion (vsn) (Huber et al., 2002) using R (http://cran.r-project.org/) and Bio-1086 Cell Reports 9, 1075–1088, November 6, 2014 ª2014 The Authconductor (http://bioconductor.org) packages. Gene lists of interest were
generated from those genes >2-fold up/downregulated and with a p < 0.05
for comparison using the Venn diagram module of GenePattern (Gould
et al., 2006). Heatmaps were generated using GENE-E (http://www.
broadinstitute.org/cancer/software/GENE-E/index.html). Gene set enrich-
ment analysis was performed using GSEA version 2.0.14 (Subramanian
et al., 2005).
CyTOF
PBMCs were stimulated for 3 hr with 150 ng/ml PMA + 1 mM ionomycin in
RPMI plus brefeldin A and monensin (eBioscience), 2.5 mg/ml anti-CD107a,
1.25 mg/ml anti-CD107b (BD Bioscience), and 10 mM TAPI-2 (VWR Interna-
tional). Following stimulation, cells were resuspended in cytometry buffer
(PBS + 0.05% sodium azide + 2 mM EDTA + 2% fetal calf serum) and stained
with isotope-tagged antibodies before being acquired on the CyTOF. For the
detailed protocol, see Newell et al. (2012) and the Supplemental Experimental
Procedures.
Statistical Analysis
Statistical analysis was performed using Prism version 6 software (GraphPad).
Data are represented as mean ± SEM. ****p < 0.0001; ***p < 0.001; **p < 0.01;
*p < 0.05; and ns, not significant, as stated in figure legends.
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